Politics Analysts Rate Upstream Bio (NASDAQ:UPB) as Outperform with $40 Target Investment analysts at Evercore ISI have initiated coverage of Upstream Bio (NASDAQ:UPB) with an outperform rating and a price target of $40.00 per share,... Editorial1 hour ago